ICU Medical Inc (ICUI) - Cash Flow Conversion Efficiency
Based on the latest financial reports, ICU Medical Inc (ICUI) has a cash flow conversion efficiency ratio of 0.029x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($60.60 Million) by net assets ($2.12 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Check ICUI strategic asset allocation to assess the company's strategic physical and investment asset allocation.
ICU Medical Inc - Cash Flow Conversion Efficiency Trend (1991–2025)
This chart illustrates how ICU Medical Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. See ICU Medical Inc book value and equity for net asset value and shareholders' equity analysis.
ICU Medical Inc Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of ICU Medical Inc ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Guangzhou Baiyun International Airport Co Ltd
SHG:600004
|
0.048x |
|
Towne Bank
NASDAQ:TOWN
|
0.040x |
|
Seek Ltd
AU:SEK
|
0.064x |
|
Hefei Chipmore Technology Co. Ltd. A
SHG:688352
|
N/A |
|
Catena AB
ST:CATE
|
0.001x |
|
CJ Corp
KO:001040
|
0.099x |
|
Liechtensteinische Landesbank Aktiengesellschaft
F:LLS1
|
-0.061x |
|
Keboda Technology Co Ltd
SHG:603786
|
0.045x |
Annual Cash Flow Conversion Efficiency for ICU Medical Inc (1991–2025)
The table below shows the annual cash flow conversion efficiency of ICU Medical Inc from 1991 to 2025. For the full company profile with market capitalisation and key ratios, see ICUI market cap.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2025-12-31 | $2.12 Billion | $179.85 Million | 0.085x | -18.44% |
| 2024-12-31 | $1.97 Billion | $204.03 Million | 0.104x | +32.64% |
| 2023-12-31 | $2.12 Billion | $166.20 Million | 0.078x | +363.29% |
| 2022-12-31 | $2.09 Billion | $-62.13 Million | -0.030x | -117.96% |
| 2021-12-31 | $1.62 Billion | $267.54 Million | 0.166x | +11.65% |
| 2020-12-31 | $1.50 Billion | $222.75 Million | 0.148x | +100.37% |
| 2019-12-31 | $1.38 Billion | $101.92 Million | 0.074x | -41.63% |
| 2018-12-31 | $1.26 Billion | $160.22 Million | 0.127x | -1.62% |
| 2017-12-31 | $1.20 Billion | $154.42 Million | 0.129x | -5.41% |
| 2016-12-31 | $660.15 Million | $89.94 Million | 0.136x | +44.00% |
| 2015-12-31 | $579.87 Million | $54.87 Million | 0.095x | -20.70% |
| 2014-12-31 | $508.25 Million | $60.64 Million | 0.119x | -13.39% |
| 2013-12-31 | $464.73 Million | $64.02 Million | 0.138x | -18.75% |
| 2012-12-31 | $390.86 Million | $66.27 Million | 0.170x | -15.03% |
| 2011-12-31 | $323.16 Million | $64.49 Million | 0.200x | +65.39% |
| 2010-12-31 | $274.29 Million | $33.09 Million | 0.121x | -34.22% |
| 2009-12-31 | $265.00 Million | $48.61 Million | 0.183x | +53.55% |
| 2008-12-31 | $253.03 Million | $30.23 Million | 0.119x | -38.44% |
| 2007-12-31 | $213.90 Million | $41.51 Million | 0.194x | +38.30% |
| 2006-12-31 | $225.25 Million | $31.61 Million | 0.140x | -2.53% |
| 2005-12-31 | $190.12 Million | $27.37 Million | 0.144x | -10.42% |
| 2004-12-31 | $157.31 Million | $25.28 Million | 0.161x | +9.83% |
| 2003-12-31 | $156.00 Million | $22.83 Million | 0.146x | -24.28% |
| 2002-12-31 | $145.39 Million | $28.10 Million | 0.193x | -15.26% |
| 2001-12-31 | $106.68 Million | $24.33 Million | 0.228x | +49.03% |
| 2000-12-31 | $83.38 Million | $12.76 Million | 0.153x | -29.69% |
| 1999-12-31 | $68.00 Million | $14.80 Million | 0.218x | +91.93% |
| 1998-12-31 | $58.20 Million | $6.60 Million | 0.113x | -37.56% |
| 1997-12-31 | $47.90 Million | $8.70 Million | 0.182x | +30.49% |
| 1996-12-31 | $46.70 Million | $6.50 Million | 0.139x | -9.13% |
| 1995-12-31 | $45.70 Million | $7.00 Million | 0.153x | +320.37% |
| 1994-12-31 | $24.70 Million | $900.00K | 0.036x | -76.26% |
| 1993-12-31 | $21.50 Million | $3.30 Million | 0.153x | -10.47% |
| 1992-12-31 | $17.50 Million | $3.00 Million | 0.171x | -89.14% |
| 1991-12-31 | $1.90 Million | $3.00 Million | 1.579x | -- |
About ICU Medical Inc
ICU Medical, Inc., together with its subsidiaries, develops, manufactures, and sells medical products used in infusion therapy, vascular access, and vital care applications worldwide. It offers Clave needlefree products under the MicroClave, MicroClave Clear, and NanoClave brands; Neutron catheter patency devices; ChemoLock closed system transfer devices and ChemoClaveTM for preparation and admin… Read more